{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/herpes-simplex-oral/diagnosis/assessment/","result":{"pageContext":{"chapter":{"id":"e37bcee1-69de-5e61-9294-81ff5642fa57","slug":"assessment","fullItemName":"Assessment","depth":2,"htmlHeader":"<!-- begin field 128ce25a-4921-4ace-ab36-c4c070ade23a --><h2>How should I assess a person with oral herpes simplex?</h2><!-- end field 128ce25a-4921-4ace-ab36-c4c070ade23a -->","summary":"","htmlStringContent":"<!-- begin item 34600326-6ee4-4219-babb-ba30e2958203 --><!-- begin field 05ca7d17-463a-4b9f-87c2-25c47ddf38f2 --><p><strong>In a person presenting with <a class=\"topic-reference internal-reference\" href=\"/topics/herpes-simplex-oral/diagnosis/diagnosis/\">suspected oral herpes simplex</a>:</strong></p><ul><li><strong>Ask about:</strong><ul><li>The location of lesions.</li><li>The frequency and duration of lesions.</li><li>Associated <a class=\"topic-reference internal-reference\" href=\"/topics/herpes-simplex-oral/diagnosis/diagnosis/\">symptoms</a>, such as pain.</li><li>The impact on the person, such as embarrassment or emotional distress.</li><li>Known trigger factors, such as ultraviolet light, physical or emotional stress, fatigue, fever, menstruation, immunosuppression, extremes in temperature, mouth or lip trauma to the area of primary infection, and dental or surgical procedures.</li><li>Any associated <a class=\"topic-reference internal-reference\" href=\"/topics/herpes-simplex-oral/background-information/complications/\">complications</a>.</li><li>Any underlying medical conditions that may affect the <a class=\"topic-reference internal-reference\" href=\"/topics/herpes-simplex-oral/background-information/prognosis/\">course</a> of herpes simplex infection, such as immunosuppression or atopic eczema.</li></ul></li><li><strong>Assess for any red flags that may suggest more serious underlying disease such as oral cancer, including:</strong><ul><li>Unexplained ulceration in the oral cavity lasting for more than 3 weeks.</li><li>A suspicious lump on the lip or in the oral cavity.</li><li>A red, or red and white, patch in the oral cavity consistent with erythroplakia or erythroleukoplakia.</li><li>For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/head-neck-cancers-recognition-referral/\">Head and neck cancers - recognition and referral</a>.</li></ul></li><li><strong>Investigations are not usually necessary in primary care.</strong><ul><li>If a person presents with unexplained recurrent infections which are severe or persistent, consider arranging investigations for underlying immunosuppression, such as HIV infection, depending on clinical judgement. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/hiv-infection-aids/\">HIV infection and AIDS</a>.</li></ul></li></ul><!-- end field 05ca7d17-463a-4b9f-87c2-25c47ddf38f2 --><!-- end item 34600326-6ee4-4219-babb-ba30e2958203 -->","topic":{"id":"401dad14-da6a-5b54-bb3d-2cfea5661d4b","topicId":"5f875f0c-db78-44fb-b672-bd54c9216205","topicName":"Herpes simplex - oral","slug":"herpes-simplex-oral","lastRevised":"Last revised in October 2016","chapters":[{"id":"2106bbf3-357c-5e99-8faf-4898c1ca935e","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"83c52d0f-97ef-5a31-8ff4-41d30aff63ad","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"88707caf-63e9-5b1e-bd0d-adca6b1e4d1b","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"0b1ea486-a30d-554a-87c3-68b2a981d26d","slug":"changes","fullItemName":"Changes"},{"id":"96fd5acc-0417-54f9-8185-fd7234a33908","slug":"update","fullItemName":"Update"}]},{"id":"56d4e2ce-1a2c-5bbf-9a02-d7ec1fe80537","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"abbdfc66-bff5-502d-ad7d-32c81000d0f2","slug":"goals","fullItemName":"Goals"},{"id":"b3a9824a-ae33-5fa9-81e7-a932b005c125","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"f2bb54c7-b5b0-5b30-a704-921dce3f32c9","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"d3f7ec4d-ecc0-5956-b6b6-22c492e1122f","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"9944dadf-7acf-5f24-8f20-c050c044edba","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"425c65b2-de3b-5863-b73c-72199baee6f1","slug":"nice-quality-standards","fullItemName":"NICE Quality standards"}]},{"id":"5749e0ab-cd7c-5a50-bc2c-ef816e9599c2","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"1d630313-1e41-59ae-8ae9-5cd26302276f","slug":"definition","fullItemName":"Definition"},{"id":"31a0a436-27cb-58e7-949b-76fb6dbd9c54","slug":"transmission","fullItemName":"Transmission"},{"id":"98ffdaac-76d5-54c1-93f5-7dd4a2f9148b","slug":"prevalence","fullItemName":"Prevalence"},{"id":"bf160e19-7acf-5ed0-9c7a-be8eeb5b5d1c","slug":"complications","fullItemName":"Complications"},{"id":"739ee047-f37b-56ca-ae40-7c3875158ee6","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"bc2ab338-32ce-50dc-8b2b-3546b85d2d9f","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"78e575da-c305-5bf9-b61a-f062ae2c4eb5","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"e37bcee1-69de-5e61-9294-81ff5642fa57","slug":"assessment","fullItemName":"Assessment"},{"id":"ed37f634-077a-5cf4-880d-5d2e9e5e5d9c","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"ca77797d-b745-54df-ae5b-ca78f5b20941","fullItemName":"Management","slug":"management","subChapters":[{"id":"3270af1a-6907-5c03-9ffb-c4d827c56103","slug":"herpes-labialis-gingivostomatitis","fullItemName":"Scenario: Herpes labialis and gingivostomatitis"}]},{"id":"059e9ce0-0874-50ea-b177-6ae9c92398c4","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"8416d8f1-2061-51a1-b6ab-29d314b7738e","slug":"analgesia","fullItemName":"Analgesia"},{"id":"eeff86e7-c71a-5781-a929-0698c0bcfc16","slug":"oral-antiviral-drugs","fullItemName":"Oral antiviral drugs"}]},{"id":"3a06d913-863d-5a7d-a6ce-6f327e1db685","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"981bfc0e-bf2d-528d-a298-5ed824004d46","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"d4db274b-f8f9-559e-8053-48f1712ad1f3","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"1ee8a0ab-5883-561f-9aed-2524df466dfb","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"1c48988f-4b5b-512c-90dc-8f7341fd9a0f","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"e1757009-f8a2-561e-9c49-0048e0c195b9","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"9fbce5d9-f27e-5f7c-8744-4b00ad58e71d","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"d5966d8c-2014-541a-bd9b-fbab33577d44","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"bc2ab338-32ce-50dc-8b2b-3546b85d2d9f","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"e051082d-9c3a-525e-9abe-bce7d3fa61fd","slug":"basis-for-recommendation-e15","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field 019ed5e2-d68a-47cf-bfa2-dce197dbb69f --><h3>Basis for recommendation</h3><!-- end field 019ed5e2-d68a-47cf-bfa2-dce197dbb69f -->","summary":null,"htmlStringContent":"<!-- begin item e15e167e-7c7d-400c-9c50-d64e918c1de4 --><!-- begin field 63b6595a-15e8-4cae-9a5c-765e42840eec --><h4>Features of the initial assessment</h4><p>The recommendations on how to assess a person with suspected oral herpes simplex infection are largely based on expert opinion in a Cochrane systematic review protocol <em>Interventions for treatment of herpes simplex labialis (cold sores on the lips)</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/herpes-simplex-oral/references/\">Lee et al, 2011</a>], a British Medical Journal (BMJ) Clinical Evidence systematic review article on herpes labialis [<a class=\"bibliography-reference internal-reference\" href=\"/topics/herpes-simplex-oral/references/\">Chi, 2015</a>], and expert opinion in international review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/herpes-simplex-oral/references/\">Raborn and Grace, 2003</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/herpes-simplex-oral/references/\">Usatine and Tinitigan, 2010a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/herpes-simplex-oral/references/\">Cunningham et al, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/herpes-simplex-oral/references/\">Stoopler et al, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/herpes-simplex-oral/references/\">Stoopler and Sollecito, 2014</a>].</p><ul><li>People with herpes labialis often express feelings of embarrassment and stigma due to the presence of disfiguring lesions [<a class=\"bibliography-reference internal-reference\" href=\"/topics/herpes-simplex-oral/references/\">Lee et al, 2011</a>].</li><li>Underlying immunosuppression may increase the risk of recurrent and/or severe infections, and a history of atopic eczema may increase the risk of the complication eczema herpeticum [<a class=\"bibliography-reference internal-reference\" href=\"/topics/herpes-simplex-oral/references/\">Lee et al, 2011</a>].</li></ul><h4>Red flags for oral cancer</h4><ul><li>The information on red flags for oral cancer is based on the National Institute for Health and Care Excellence (NICE) clinical guideline <em>Suspected cancer: recognition and referral</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/herpes-simplex-oral/references/\">NICE, 2015</a>].</li></ul><h4>Investigations not usually needed in primary care</h4><ul><li>This recommendation is based on expert opinion in a review article, as the diagnosis is usually made on clinical features alone [<a class=\"bibliography-reference internal-reference\" href=\"/topics/herpes-simplex-oral/references/\">Stoopler et al, 2012</a>].<ul><li>Herpes simplex virus (HSV) can be detected, and the type determined, using viral culture from skin vesicles. Early in the course of infection, 80–90% of viral cultures from untreated lesions are positive, but the false-negative rate increases 24–48 hours after the lesions have appeared [<a class=\"bibliography-reference internal-reference\" href=\"/topics/herpes-simplex-oral/references/\">Usatine and Tinitigan, 2010a</a>]. As a result, the diagnostic yield may be poor in people attending primary care. Alternative tests include polymerase chain reaction (PCR), which is a more sensitive method, however these tests are not universally available in primary care.</li></ul></li><li>The recommendation to consider arranging investigations for underlying immunosuppression if a person presents with unexplained recurrent episodes which are frequent or severe is based on a Cochrane systematic review protocol [<a class=\"bibliography-reference internal-reference\" href=\"/topics/herpes-simplex-oral/references/\">Lee et al, 2011</a>] and expert opinion in a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/herpes-simplex-oral/references/\">Cunningham et al, 2012</a>], and is pragmatic, based on what CKS considers to be good clinical practice.</li></ul><!-- end field 63b6595a-15e8-4cae-9a5c-765e42840eec --><!-- end item e15e167e-7c7d-400c-9c50-d64e918c1de4 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}